Natera Net Income 2014-2024 | NTRA
Natera annual/quarterly net income history and growth rate from 2014 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Natera net income for the quarter ending December 31, 2024 was $-0.054B, a 31.09% decline year-over-year.
- Natera net income for the twelve months ending December 31, 2024 was $-0.190B, a 56.2% decline year-over-year.
- Natera annual net income for 2024 was $-0.19B, a 56.2% decline from 2023.
- Natera annual net income for 2023 was $-0.435B, a 20.63% decline from 2022.
- Natera annual net income for 2022 was $-0.548B, a 16.13% increase from 2021.
| Natera Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $-190 |
| 2023 | $-435 |
| 2022 | $-548 |
| 2021 | $-472 |
| 2020 | $-230 |
| 2019 | $-125 |
| 2018 | $-128 |
| 2017 | $-138 |
| 2016 | $-100 |
| 2015 | $-70 |
| 2014 | $-5 |
| 2013 | $-37 |
| Natera Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-54 |
| 2024-09-30 | $-32 |
| 2024-06-30 | $-37 |
| 2024-03-31 | $-68 |
| 2023-12-31 | $-78 |
| 2023-09-30 | $-109 |
| 2023-06-30 | $-111 |
| 2023-03-31 | $-137 |
| 2022-12-31 | $-143 |
| 2022-09-30 | $-121 |
| 2022-06-30 | $-145 |
| 2022-03-31 | $-139 |
| 2021-12-31 | $-141 |
| 2021-09-30 | $-151 |
| 2021-06-30 | $-116 |
| 2021-03-31 | $-64 |
| 2020-12-31 | $-76 |
| 2020-09-30 | $-58 |
| 2020-06-30 | $-60 |
| 2020-03-31 | $-35 |
| 2019-12-31 | $-35 |
| 2019-09-30 | $-23 |
| 2019-06-30 | $-32 |
| 2019-03-31 | $-34 |
| 2018-12-31 | $-32 |
| 2018-09-30 | $-30 |
| 2018-06-30 | $-34 |
| 2018-03-31 | $-33 |
| 2017-12-31 | $-47 |
| 2017-09-30 | $-28 |
| 2017-06-30 | $-29 |
| 2017-03-31 | $-33 |
| 2016-12-31 | $-42 |
| 2016-09-30 | $-26 |
| 2016-06-30 | $-23 |
| 2016-03-31 | $-9 |
| 2015-12-31 | $-23 |
| 2015-09-30 | $-18 |
| 2015-06-30 | $-20 |
| 2015-03-31 | $-10 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $-1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.836B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.350B | 26.32 |
| Elevance Health (ELV) | United States | $91.117B | 11.76 |
| CVS Health (CVS) | United States | $79.102B | 9.83 |
| Cencora (COR) | United States | $56.251B | 19.57 |
| DiDi Global (DIDIY) | China | $21.979B | 33.36 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.822B | 13.57 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.604B | 0.00 |
| CochLear (CHEOY) | Australia | $11.282B | 0.00 |
| Revvity (RVTY) | United States | $10.993B | 18.92 |
| ICON (ICLR) | Ireland | $10.630B | 9.88 |
| Viatris (VTRS) | United States | $10.375B | 3.56 |
| Doximity (DOCS) | United States | $9.813B | 45.70 |
| Avantor (AVTR) | United States | $9.138B | 13.28 |
| Medpace Holdings (MEDP) | United States | $8.785B | 23.33 |
| HealthEquity (HQY) | United States | $8.497B | 41.80 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.924B | 13.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.257B | 39.40 |
| Bausch + Lomb (BLCO) | Canada | $4.156B | 24.50 |
| Sotera Health (SHC) | United States | $3.633B | 20.65 |
| Alignment Healthcare (ALHC) | United States | $3.122B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.068B | 39.90 |
| Concentras Parent (CON) | United States | $2.912B | 16.83 |
| Organon (OGN) | United States | $2.350B | 2.50 |
| Ardent Health Partners (ARDT) | United States | $2.204B | 9.40 |
| GeneDx Holdings (WGS) | United States | $1.949B | 75.07 |
| Progyny (PGNY) | United States | $1.912B | 42.08 |
| Premier (PINC) | United States | $1.904B | 14.45 |
| PACS (PACS) | United States | $1.647B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.414B | 28.29 |
| Teladoc Health (TDOC) | United States | $1.319B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.283B | 9.76 |
| Establishment Labs Holdings (ESTA) | $1.046B | 0.00 | |
| Agilon Health (AGL) | United States | $1.014B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 15.25 |
| Nutex Health (NUTX) | United States | $0.972B | 14.69 |
| AMN Healthcare Services Inc (AMN) | United States | $0.869B | 8.13 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.702B | 4.73 |
| InnovAge Holding (INNV) | United States | $0.566B | 0.00 |
| Enhabit (EHAB) | United States | $0.539B | 44.33 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.494B | 0.00 |
| LifeMD (LFMD) | United States | $0.487B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.370B | 0.00 |
| SBC Medicals (SBC) | United States | $0.352B | 0.00 |
| Oncology Institute (TOI) | United States | $0.226B | 0.00 |
| Beauty Health (SKIN) | United States | $0.218B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.150B | 24.50 |
| Sera Prognostics (SERA) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| KindlyMD (KDLY) | United States | $0.078B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |